亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

武漢遠啟醫(yī)藥化工有限公司  

化工產(chǎn)品,醫(yī)藥中間體,醫(yī)藥原料銷售

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:余攀
  • 電話:027-88080696
  • 郵件:Pharmyuanqi@gmail.com
  • 傳真:027-88082096
  • QQ:1169749983
站內(nèi)搜索
 
榮譽資質(zhì)
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 供應(yīng)格列喹酮(糖腎平)
供應(yīng)格列喹酮(糖腎平)
單價 5800.00 / kg對比
銷量 暫無
發(fā)貨 湖北武漢市付款后48小時內(nèi)
庫存 100kg起訂1kg
品牌 遠啟醫(yī)藥
型號 33342-05-1
規(guī)格 BP2007
過期 長期有效
更新 2019-02-19 10:15
 
詳細信息

格列喹酮(糖腎平)
英文名:Gliquidone
化學名:3-環(huán)己基-1-[4-[2-(3,4-二氫-7-甲氧基-4,4-二甲基-1,3-雙氧基-2-(1H)-異喹啉基)-乙基]苯基]磺酰基-脲
CAS: 33342-05-1;   含量:≥99% ; 總雜<1%
質(zhì)量標準:BP2007
分子式:C27H33N3O6S;  分子量:527.63;   熔點:176 -181 ℃
性狀:白色粉末
包裝:5kg/紙板桶;1kg/鋁箔袋       
貯藏:遮光,密閉保存。
用途:第二代磺脲類口服降血糖藥。
©2025 武漢遠啟醫(yī)藥化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:26911  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |